Captrust Financial Advisors Simulations Plus, Inc. Transaction History

Captrust Financial Advisors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$38.46 - $50.95 $1.74 Million - $2.3 Million	45,229 New	45,229 $2.2 Million
Q4 2023 Feb 14, 2024	BUY	$33.36 - $45.71 $156,224 - $214,059	4,683 New	4,683 $209,000
Q2 2022 Aug 16, 2022	BUY	$40.55 - $51.76 $851 - $1,086	21 Added 42.86%	70 $3,000
Q1 2022 May 16, 2022	SELL	$36.56 - $50.98 $3,180 - $4,435	-87 Reduced 63.97%	49 $2,000
Q3 2021 Nov 16, 2021	SELL	$38.45 - $55.66 $5,498 - $7,959	-143 Reduced 51.25%	136 $5,000
Q2 2021 Aug 16, 2021	SELL	$49.67 - $68.96 $943 - $1,310	-19 Reduced 6.38%	279 $15,000
Q1 2021 May 17, 2021	SELL	$60.06 - $89.52 $1,321 - $1,969	-22 Reduced 6.88%	298 $19,000
Q4 2020 Feb 16, 2021	BUY	$53.26 - $77.18 $17,043 - $24,697	320 New	320 $23,000
Q4 2018 Feb 13, 2019	SELL	$17.56 - $21.2 $2,528 - $3,052	-144 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$17.1 - $23.55 $2,462 - $3,391	144 New	144 $3,000

175

15.1M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $584M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.